Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-022975
Filing Date
2025-08-25
Accepted
2025-08-25 21:33:50
Documents
1
Period of Report
2025-08-21

Document Format Files

Seq Description Document Type Size
1 form4-08262025_010847.html 4  
1 form4-08262025_010847.xml 4 7664
  Complete submission text file 0001415889-25-022975.txt   9446
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

EIN.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PRAXIS PRECISION MEDICINES, INC. ONE BROADWAY, 16TH FLOOR CAMBRIDGE MA 02142
Business Address
Sweeny Nicole (Reporting) CIK: 0001827505 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36830 | Film No.: 251252504